Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
주식 순위 #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
주가
$1.11
시가총액
$27.17M
변동 (1일)
0.19%
변동 (1년)
58.22%
국가
KR
거래 Dong Sung Bio Pharm.Co.,Ltd. (002210)

카테고리

Dong Sung Bio Pharm.Co.,Ltd. (002210)의 매출
Mar 2026 기준 매출 TTM: $55.28M
Dong Sung Bio Pharm.Co.,Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $55.28M입니다. 2023년에 회사는 $68.44M의 수익을 올렸으며 이는 2022년의 $73.96M 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Dong Sung Bio Pharm.Co.,Ltd.의 수익 기록 (2007 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $55.28M -8.11%
2024 $60.16M -12.09%
2023 $68.44M -7.47%
2022 $73.96M 4.17%
2021 $71.00M -12.21%
2020 $80.87M 7.92%
2019 $74.94M -9.21%
2018 $82.54M 6.78%
2017 $77.30M 16.92%
2016 $66.12M 4.07%
2015 $63.53M -4.97%
2014 $66.85M -6.37%
2013 $71.41M -10.13%
2012 $79.45M 17.40%
2011 $67.68M 5.52%
2010 $64.14M 8.31%
2009 $59.22M 22.81%
2008 $48.22M -25.17%
2007 $64.44M 0.00%
유사 기업 또는 경쟁사의 매출